$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss

$mlss Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-K Financial Statement

#000143774920006563 Filed on March 30, 2020

Income Statement

Concept	2019 Q4	2018 Q4	2018
Revenue	$2.301M	$3.766M	$9.622M
YoY Change	-38.9%	69.63%	-14.71%
Cost Of Revenue	$761.6K	$1.864M	$5.191M
YoY Change	-59.15%	88.33%	20.37%
Gross Profit	$1.539M	$1.901M	$4.431M
YoY Change	-19.04%	55.84%	-36.42%
Gross Profit Margin	66.9%	50.49%	46.05%
Selling, General & Admin	$2.585M	$1.897M	$10.65M
YoY Change	36.31%	-35.27%	-10.78%
% of Gross Profit	167.96%	99.76%	240.23%
Research & Development	$80.11K	$29.98K	$245.6K
YoY Change	167.21%	-0.07%	-9.94%
% of Gross Profit	5.2%	1.58%	5.54%
Depreciation & Amortization	$23.59K	$26.17K	$881.3K
YoY Change	-9.86%	-92.3%	53.76%
% of Gross Profit	1.53%	1.38%	19.89%
Operating Expenses	$2.666M	$1.927M	$12.43M
YoY Change	38.35%	-35.13%	1.86%
Operating Profit	-$1.126M	-$25.41K	-$7.999M
YoY Change	4332.31%	-98.55%	52.82%
Interest Expense	-$1.789M	$1.310K	$7.450K
YoY Change	-136639.69%		-19.89%
% of Operating Profit
Other Income/Expense, Net	-$2.950K	-$1.990K	-$7.232K
YoY Change	48.24%		46.69%
Pretax Income	-$2.918M	-$26.09K	-$7.999M
YoY Change	11083.83%	-98.5%	52.95%
Income Tax	-$1.750K	$6.830K	$23.99K
% Of Pretax Income
Net Earnings	-$2.863M	$179.9K	-$7.432M
YoY Change	-1691.91%	-110.05%	43.28%
Net Earnings / Revenue	-124.44%	4.78%	-77.24%
Basic Earnings Per Share			-$0.21
Diluted Earnings Per Share	-$54.00K	$5.005K	-$0.21
COMMON SHARES
Basic Shares Outstanding			35.30M
Diluted Shares Outstanding			35.30M

Balance Sheet

Concept	2019 Q4	2018 Q4	2018
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.516M	$743.4K	$743.4K
YoY Change	103.96%	-71.84%	-71.81%
Cash & Equivalents	$1.516M	$1.996M	$743.4K
Short-Term Investments
Other Short-Term Assets	$519.1K	$464.5K	$464.5K
YoY Change	11.74%	-70.03%	-69.95%
Inventory	$1.621M	$1.921M	$2.570M
Prepaid Expenses
Receivables	$1.711M	$1.978M	$2.078M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$6.077M	$5.856M	$5.856M
YoY Change	3.77%	-51.28%	-51.28%
LONG-TERM ASSETS
Property, Plant & Equipment	$44.98K	$82.56K	$82.56K
YoY Change	-45.52%	-41.76%	-41.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$35.91K	$26.88K	$26.88K
YoY Change	33.59%	0.0%	0.0%
Total Long-Term Assets	$479.1K	$544.7K	$544.7K
YoY Change	-12.04%	-84.9%	-84.9%
TOTAL ASSETS
Total Short-Term Assets	$6.077M	$5.856M	$5.856M
Total Long-Term Assets	$479.1K	$544.7K	$544.7K
Total Assets	$6.556M	$6.401M	$6.401M
YoY Change	2.43%	-59.04%	-59.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.379M	$1.059M	$2.869M
YoY Change	30.23%	8.34%	46.14%
Accrued Expenses	$775.1K	$794.9K	$1.482M
YoY Change	-2.5%	-63.52%	-35.24%
Deferred Revenue		$100.0K
YoY Change		-94.2%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.900K
YoY Change
Total Short-Term Liabilities	$4.928M	$4.873M	$4.873M
YoY Change	1.13%	-27.58%	-27.58%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$0.00
YoY Change		-100.0%
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.928M	$4.873M	$4.873M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$4.928M	$4.873M	$4.861M
YoY Change	1.13%	-40.05%	-42.02%
SHAREHOLDERS EQUITY
Retained Earnings	-$93.52M	-$86.00M
YoY Change	8.75%	9.46%
Common Stock	$96.13M	$88.45M
YoY Change	8.68%	1.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$911.5K	$911.5K
YoY Change	0.0%	0.0%
Treasury Stock Shares	$33.33K	$33.33K
Shareholders Equity	$1.696M	$1.540M	$1.540M
YoY Change
Total Liabilities & Shareholders Equity	$6.556M	$6.401M	$6.401M
YoY Change	2.43%	-59.04%	-59.04%

Cashflow Statement

Concept	2019 Q4	2018 Q4	2018
OPERATING ACTIVITIES
Net Income	-$2.863M	$179.9K	-$7.432M
YoY Change	-1691.91%	-110.05%	43.28%
Depreciation, Depletion And Amortization	$23.59K	$26.17K	$881.3K
YoY Change	-9.86%	-92.3%	53.76%
Cash From Operating Activities	-$503.6K	$329.5K	-$1.628M
YoY Change	-252.84%	-0.15%	32.43%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$890.00	$7.401K
YoY Change	-100.0%		23.19%
Acquisitions
YoY Change
Other Investing Activities		$0.00	-$8.020K
YoY Change
Cash From Investing Activities	$0.00	-$890.00	-$15.42K
YoY Change	-100.0%		-92.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	308.6K	0.000	-250.0K
YoY Change			-153.96%
NET CHANGE
Cash From Operating Activities	-503.6K	329.5K	-1.628M
Cash From Investing Activities	0.000	-890.0	-15.42K
Cash From Financing Activities	308.6K	0.000	-250.0K
Net Change In Cash	-195.0K	328.6K	-1.894M
YoY Change	-159.33%	-0.42%	96.16%
FREE CASH FLOW
Cash From Operating Activities	-$503.6K	$329.5K	-$1.628M
Capital Expenditures	$0.00	-$890.00	$7.401K
Free Cash Flow	-$503.6K	$330.4K	-$1.636M
YoY Change	-252.43%	0.12%	32.38%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2019	dei	Amendment Flag AmendmentFlag	false
CY2019	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019	dei	Document Period End Date DocumentPeriodEndDate	2019-12-31
CY2019	dei	Document Type DocumentType	10-K
CY2019	dei	Entity Central Index Key EntityCentralIndexKey	0000855683
CY2020Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	49410176
CY2019	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2019	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2019Q2	dei	Entity Public Float EntityPublicFloat	15368647
CY2019	dei	Entity Registrant Name EntityRegistrantName	MILESTONE SCIENTIFIC INC.
CY2019	dei	Entity Shell Company EntityShellCompany	false
CY2019	dei	Entity Small Business EntitySmallBusiness	true
CY2019	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2019	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2019	dei	Security12b Title Security12bTitle	Common Stock, par value $.001 per share
CY2019	dei	Trading Symbol TradingSymbol	mlss
CY2019Q4	mlss	Accrued Expenses Related Party AccruedExpensesRelatedParty	1057957
CY2018Q4	mlss	Accrued Expenses Related Party AccruedExpensesRelatedParty	686798
CY2005Q1	mlss	Additional Percentage Of Director Compensation On Sales Value Using Certain Specify Technology AdditionalPercentageOfDirectorCompensationOnSalesValueUsingCertainSpecifyTechnology	0.025
CY2005Q1	mlss	Additional Percentage Of Director Compensation Sales Value Using Other Kind Of Technology AdditionalPercentageOfDirectorCompensationSalesValueUsingOtherKindOfTechnology	0.05
CY2019	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	1724882
CY2018	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	789957
CY2019Q4	mlss	Adjustments To Additional Paid In Capital Reclassification Of Derivative Liability To Equity AdjustmentsToAdditionalPaidInCapitalReclassificationOfDerivativeLiabilityToEquity	2640000
	mlss	Adjustments To Additional Paid In Capital Reclassification Of Derivative Liability To Equity AdjustmentsToAdditionalPaidInCapitalReclassificationOfDerivativeLiabilityToEquity	2700000
CY2019	mlss	Adjustments To Additional Paid In Capital Reclassification Of Derivative Liability To Equity AdjustmentsToAdditionalPaidInCapitalReclassificationOfDerivativeLiabilityToEquity	4115778
CY2019	mlss	Adjustments To Additional Paid In Capital Reclassification Of Derivative Liability To Option AdjustmentsToAdditionalPaidInCapitalReclassificationOfDerivativeLiabilityToOption	380000
CY2019	mlss	Adjustments To Additional Paid In Capital Shares To Be Issued AdjustmentsToAdditionalPaidInCapitalSharesToBeIssued	1070000
CY2019	mlss	Adjustments To Additional Paid In Capital Warrants Exercised AdjustmentsToAdditionalPaidInCapitalWarrantsExercised	650000
CY2019Q4	mlss	Adjustments To Additional Paid In Capital Warrants Exercised And Shares To Be Issued AdjustmentsToAdditionalPaidInCapitalWarrantsExercisedAndSharesToBeIssued	4100000
CY2019	mlss	Amortization Of Right Of Use Assets AmortizationOfRightOfUseAssets	155962
CY2018	mlss	Amortization Of Right Of Use Assets AmortizationOfRightOfUseAssets
CY2019	mlss	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	675000
CY2019	mlss	Class Of Warrant Or Right Exercised During Period Exercise Price ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice	0.50
CY2019	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period ClassOfWarrantOrRightExpiredOrCancelledDuringPeriod	1592775
CY2019	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period Exercise Price ClassOfWarrantOrRightExpiredOrCancelledDuringPeriodExercisePrice	2.55
CY2019	mlss	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	1749171
CY2019	mlss	Class Of Warrant Or Right Issued During Period Exercise Price ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice	0.50
CY2019Q4	mlss	Common Stock Shares To Be Issued CommonStockSharesToBeIssued	2100000
CY2019	mlss	Credit From United Systems For Defective Handpieces CreditFromUnitedSystemsForDefectiveHandpieces	151562
CY2018	mlss	Credit From United Systems For Defective Handpieces CreditFromUnitedSystemsForDefectiveHandpieces
CY2019	mlss	Deferred Compensation Arrangement With Individual Shares Granted DeferredCompensationArrangementWithIndividualSharesGranted	2103793
CY2019	mlss	Deferred Cost Reserve DeferredCostReserve
CY2018	mlss	Deferred Cost Reserve DeferredCostReserve	1250928
CY2019Q4	mlss	Deferred Profit Related Parties Current DeferredProfitRelatedPartiesCurrent	340476
CY2018Q4	mlss	Deferred Profit Related Parties Current DeferredProfitRelatedPartiesCurrent	421800
CY2019Q4	mlss	Deferred Tax Assets Depreciation And Amortization Noncurrent DeferredTaxAssetsDepreciationAndAmortizationNoncurrent	-103000
CY2018Q4	mlss	Deferred Tax Assets Depreciation And Amortization Noncurrent DeferredTaxAssetsDepreciationAndAmortizationNoncurrent	345000
CY2019	mlss	Effective Income Tax Rate Reconciliation At Federal Statutory Rate And State And Local Income Tax Rate And Stockbased Compensation EffectiveIncomeTaxRateReconciliationAtFederalStatutoryRateAndStateAndLocalIncomeTaxRateAndStockbasedCompensation	-0.11
CY2018	mlss	Effective Income Tax Rate Reconciliation At Federal Statutory Rate And State And Local Income Tax Rate And Stockbased Compensation EffectiveIncomeTaxRateReconciliationAtFederalStatutoryRateAndStateAndLocalIncomeTaxRateAndStockbasedCompensation	0.28
CY2019	mlss	Effective Income Tax Rate Reconciliation Net Operating Loss Percent EffectiveIncomeTaxRateReconciliationNetOperatingLossPercent	-0.22
CY2018	mlss	Effective Income Tax Rate Reconciliation Net Operating Loss Percent EffectiveIncomeTaxRateReconciliationNetOperatingLossPercent	0
CY2019	mlss	Effective Income Tax Rate Reconciliation Warrant Reevaluation Adjustment Percent EffectiveIncomeTaxRateReconciliationWarrantReevaluationAdjustmentPercent	-0.11
CY2018	mlss	Effective Income Tax Rate Reconciliation Warrant Reevaluation Adjustment Percent EffectiveIncomeTaxRateReconciliationWarrantReevaluationAdjustmentPercent	0
CY2019	mlss	Equity Method Investment Summarized Financial Information Other Expenses EquityMethodInvestmentSummarizedFinancialInformationOtherExpenses	3996663
CY2018	mlss	Equity Method Investment Summarized Financial Information Other Expenses EquityMethodInvestmentSummarizedFinancialInformationOtherExpenses	1371085
CY2019Q4	mlss	Finitelived Intangible Assets Accumulated Impairment FinitelivedIntangibleAssetsAccumulatedImpairment
CY2018Q4	mlss	Finitelived Intangible Assets Accumulated Impairment FinitelivedIntangibleAssetsAccumulatedImpairment	-1539794
CY2019	mlss	Gain Loss From Warrants Exercised GainLossFromWarrantsExercised	-500000
CY2019	mlss	Gain Loss On Issuance Of Shares To Be Issued GainLossOnIssuanceOfSharesToBeIssued	-500000
CY2019Q4	mlss	Gain Loss On Liability Classified Shares To Be Issued GainLossOnLiabilityClassifiedSharesToBeIssued	-1.80
CY2019	mlss	Income From Nonemployee Options IncomeFromNonemployeeOptions	2439
CY2018	mlss	Income From Nonemployee Options IncomeFromNonemployeeOptions	9384
CY2019	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-7661564
CY2018	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-8023106
CY2019	mlss	Increase Decrease In Accrued Liabilities Related Parties IncreaseDecreaseInAccruedLiabilitiesRelatedParties	1228965
CY2018	mlss	Stock Issued During Period Value Employee Bonuses StockIssuedDuringPeriodValueEmployeeBonuses	29500
CY2018	mlss	Increase Decrease In Accrued Liabilities Related Parties IncreaseDecreaseInAccruedLiabilitiesRelatedParties	-108640
CY2019	mlss	Increase Decrease To Advances To Contract Manufacturer IncreaseDecreaseToAdvancesToContractManufacturer	61879
CY2018	mlss	Increase Decrease To Advances To Contract Manufacturer IncreaseDecreaseToAdvancesToContractManufacturer	-48409
CY2019	mlss	Increase Decreasein Operating Lease Liability IncreaseDecreaseinOperatingLeaseLiability	-155962
CY2018	mlss	Increase Decreasein Operating Lease Liability IncreaseDecreaseinOperatingLeaseLiability
CY2019	mlss	Market To Market Gain Loss MarketToMarketGainLoss	-2600000
CY2019Q4	mlss	Market To Market Gain Loss MarketToMarketGainLoss	-500000
CY2019	mlss	Operating Lease Right Of Use Asset Incurred OperatingLeaseRightOfUseAssetIncurred	-166292
CY2018	mlss	Operating Lease Right Of Use Asset Incurred OperatingLeaseRightOfUseAssetIncurred
CY2019	mlss	Operating Lease Right Of Use Liability OperatingLeaseRightOfUseLiability	166292
CY2018	mlss	Operating Lease Right Of Use Liability OperatingLeaseRightOfUseLiability
CY2015Q2	mlss	Operating Leases Monthly Rent Expense OperatingLeasesMonthlyRentExpense	12522
CY2019	mlss	Overallotment Of Securities Initial Derivative Reclassifications OverallotmentOfSecuritiesInitialDerivativeReclassifications	-2203025
CY2019	mlss	Percentage Of Valuation Allowance PercentageOfValuationAllowance	1
CY2019	mlss	Proceeds From Sale Of Variable Interest Entity Shares With Agreement To Repurchase ProceedsFromSaleOfVariableInterestEntitySharesWithAgreementToRepurchase
CY2018	mlss	Proceeds From Sale Of Variable Interest Entity Shares With Agreement To Repurchase ProceedsFromSaleOfVariableInterestEntitySharesWithAgreementToRepurchase	-250000
CY2019Q4	mlss	Reclassification Of Shares To Be Issued Amount ReclassificationOfSharesToBeIssuedAmount	1400000
CY2019	mlss	Reclassification Of Shares To Be Issued Amount ReclassificationOfSharesToBeIssuedAmount	1300000
CY2019Q4	mlss	Reclassification Of Shares To Be Issued Shares ReclassificationOfSharesToBeIssuedShares	3400000
CY2019	mlss	Reclassification To Additional Paid In Capital ReclassificationToAdditionalPaidInCapital	655000
CY2019Q4	mlss	Reclassification To Additional Paid In Capital ReclassificationToAdditionalPaidInCapital	1070000
CY2019	mlss	Sale Of Variable Interest Entitys Shares SaleOfVariableInterestEntitysShares
CY2018	mlss	Sale Of Variable Interest Entitys Shares SaleOfVariableInterestEntitysShares	-1400000
CY2019	mlss	Sharebased Compensation Arrangement By Sharebased Payment Award Options Reclassified In Period SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsReclassifiedInPeriod	600000
CY2019	mlss	Sharebased Compensation Arrangement By Sharebased Payment Award Options Reclassified In Period Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsReclassifiedInPeriodValue	422000
CY2019	mlss	Shares And Warrants Issued Value Previously Classified As Derivative Liability SharesAndWarrantsIssuedValuePreviouslyClassifiedAsDerivativeLiability	655000
CY2019	mlss	Shares Issue To Board Of Directors For Services Rendered SharesIssueToBoardOfDirectorsForServicesRendered	67000
CY2018	mlss	Shares Issue To Board Of Directors For Services Rendered SharesIssueToBoardOfDirectorsForServicesRendered
CY2019	mlss	Shares Issued To Consultants In Lieu Of Cash Payments SharesIssuedToConsultantsInLieuOfCashPayments	440400
CY2018	mlss	Shares Issued To Consultants In Lieu Of Cash Payments SharesIssuedToConsultantsInLieuOfCashPayments	289750
CY2019Q4	mlss	Shares To Be Issued Marked To Market Shares SharesToBeIssuedMarkedToMarketShares	2100000
CY2019	mlss	Stock Issued During Period Shares Shares To Be Issued StockIssuedDuringPeriodSharesSharesToBeIssued	1300000
CY2019	mlss	Stock Issued During Period Shares Warrants Exercised StockIssuedDuringPeriodSharesWarrantsExercised	675000
CY2019	mlss	Stock Issued During Period Value Mandatory Conversion Of Preferred Shares To Common Stock StockIssuedDuringPeriodValueMandatoryConversionOfPreferredSharesToCommonStock
CY2019Q4	mlss	Stock Issued During Period Value Shares To Be Issued StockIssuedDuringPeriodValueSharesToBeIssued	1067826
CY2019	mlss	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	337500
CY2019	mlss	Stock Issued Employees Compensation StockIssuedEmployeesCompensation	37500
CY2018	mlss	Stock Issued Employees Compensation StockIssuedEmployeesCompensation	45000
CY2019	mlss	Stock Issued For Public Offering StockIssuedForPublicOffering	753000
CY2018	mlss	Stock Issued For Public Offering StockIssuedForPublicOffering
CY2018	mlss	Stock To Be Issued During Period Value Employee Bonuses StockToBeIssuedDuringPeriodValueEmployeeBonuses	449999
CY2018	mlss	Stock To Be Issued During Period Value Sharebased Compensation StockToBeIssuedDuringPeriodValueSharebasedCompensation	7500
CY2019	mlss	Warrants And Rights Issued Intrinsic Value WarrantsAndRightsIssuedIntrinsicValue	1556762
CY2019	mlss	Warrants And Rights Issued Weighted Average Remaining Term WarrantsAndRightsIssuedWeightedAverageRemainingTerm	P4Y36D
CY2018	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P76D
CY2019	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P4Y36D
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1379425
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1059186
CY2019Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	1358752
CY2018Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	1810058
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1710665
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1978456
CY2019Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent
CY2018Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	100000
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	775055
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	794918
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	96082324
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	88414718
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	409021
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	183888
CY2019Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	710662
CY2018Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	648783
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10000
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10000
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	53013
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	814681
CY2019Q4	us-gaap	Assets Assets	6556289
CY2018Q4	us-gaap	Assets Assets	6400968
CY2019Q4	us-gaap	Assets Current AssetsCurrent	6093148
CY2018Q4	us-gaap	Assets Current AssetsCurrent	5856260
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1516272
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	743429
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2636956
CY2019	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	772843
CY2018	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1893527
CY2018Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.55
CY2019Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.50
CY2018Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1592775
CY2019Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1074171
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49410176
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33859034
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49376843
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33825701
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	49410
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	36330
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	100000
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2656142
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5190775
CY2018Q4	us-gaap	Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance	2470566
CY2018Q4	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	2470566
CY2019Q4	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	2375760
CY2019	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	2198599
CY2019Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent
CY2018Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	50000
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17762000
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	18578000
CY2019Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	178000
CY2018Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	551000
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet
CY2018Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	16504000
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	16500000
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-28000
CY2018Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	384000
CY2018Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	820000
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	715000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	2000
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	3000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	435000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	5000
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	29000
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17762000
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	18578000
CY2019	us-gaap	Depreciation Depreciation	47495
CY2018	us-gaap	Depreciation Depreciation	66604
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	100508
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	881285
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.11
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.28
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.03
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.04
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.07
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	995603
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-2042443
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	53000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	33000
CY2019Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Liabilities EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities	17910452
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Liabilities EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities	17696393
CY2019Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity EquityMethodInvestmentSummarizedFinancialInformationEquity	-4435281
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity EquityMethodInvestmentSummarizedFinancialInformationEquity	-2504900
CY2019	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	1676143
CY2018	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	920516
CY2019Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	13475171
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	15191493
CY2019	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-2320520
CY2018	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-450569
CY2019	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	3401025
CY2018	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	1710473
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	47000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	53000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	53000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1377863
CY2018Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4017510
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	382260
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	435273
CY2019	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-3635580
CY2018	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax
CY2019	us-gaap	Gross Profit GrossProfit	5718359
CY2018	us-gaap	Gross Profit GrossProfit	4431301
CY2018	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1539794
CY2019	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-7643438
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-7999120
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	81324
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	329700
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18126
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23986
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	18000
CY2018	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	24000
CY2019	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-303346
CY2018	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	678171
CY2019	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	320239
CY2018	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	227773
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-267791
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	442943
CY2019	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-100000
CY2018	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	192540
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	273537
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	620797
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-100000
CY2018	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	192540
CY2019	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-50000
CY2018	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	191257
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-300542
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-914613
CY2019	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	9027
CY2018	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	104522
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-21869
CY2019Q4	us-gaap	Liabilities Liabilities	4927642
CY2019	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1543
CY2018	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	7447
CY2019Q4	us-gaap	Inventory Net InventoryNet	1620509
CY2018Q4	us-gaap	Inventory Net InventoryNet	1921051
CY2019Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	768000
CY2018Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	763000
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	99885
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	123918
CY2019	us-gaap	Inventory Write Down InventoryWriteDown
CY2018	us-gaap	Inventory Write Down InventoryWriteDown	543545
CY2019	us-gaap	Lease Cost LeaseCost	158218
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	16030
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	16030
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
CY2019Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	53
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6556289
CY2018Q4	us-gaap	Liabilities Liabilities	4872760
CY2019	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6400968
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4927642
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4872760
CY2019Q4	us-gaap	Minority Interest MinorityInterest	-67274
CY2018Q4	us-gaap	Minority Interest MinorityInterest	-11402
CY2018	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	8020
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2562047
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-250000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9916
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15421
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1779288
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1628106
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7524368
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-7431645
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-55872
CY2018	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-260126
CY2019Q3	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	60
CY2019	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2019	us-gaap	Open Tax Year OpenTaxYear	2016 2017 2018
CY2019	us-gaap	Operating Expenses OperatingExpenses	9717352
CY2018	us-gaap	Operating Expenses OperatingExpenses	12430636
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-3998993
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-7999335
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	158218
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	166292
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	15977
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	15977
CY2018Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	158218
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	15977
CY2018Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.092
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P73D
CY2019Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	39400000
CY2018Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	30800000
CY2018Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	0
CY2019Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	0
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	35905
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	26878
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10408
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7232
CY2019	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries
CY2018	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	8020
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets
CY2018	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9916
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7401
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	44976
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	82557
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	519063
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	414541
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	7
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	7000
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	7000
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2019	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div>  Reclassifications</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">Certain reclassifications have been made to the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> financial statements to conform to the condensed consolidated <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> financial statement presentation. These reclassification had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> effect on net loss or cash flows as previously reported.</div></div></div>
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1974547
CY2018	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock
CY2019Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	250000
CY2014Q2	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	10000000
CY2019	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	250000
CY2018	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement
CY2019	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	337500
CY2018	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises
CY2019	us-gaap	Profit Loss ProfitLoss	-7580240
CY2018	us-gaap	Profit Loss ProfitLoss	-7691771
CY2018	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	45000
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	790666
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	1695921
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	189923
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	245636
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-93524297
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-85999929
CY2019	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	8374501
CY2018	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	9622076
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9527429
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10645206
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	183888
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	409021
CY2019Q4	us-gaap	Share Price SharePrice	0.42
CY2019Q4	us-gaap	Share Price SharePrice	0.84
CY2019	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	67144
CY2018	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	286602
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	911516
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	1539610
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7500628
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1528208
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1628647
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	33333
CY2018Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	33333
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	911516
CY2019	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.</div>  Use of Estimates</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">+</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions in determining the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to the allowance for doubtful accounts, inventory valuation, and cash flow assumptions regarding evaluations for impairment of long-lived assets and going concern considerations, and valuation allowances on deferred tax assets. Actual results could differ from those estimates<div style="display: inline; font-weight: bold;">.</div></div></div></div>
CY2018Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding
CY2019Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	956012
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45740050
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35299034
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45740050
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35299034

Files In Submission

Name	View Source	Status
0001437749-20-006563-index-headers.html	Edgar Link	pending
0001437749-20-006563-index.html	Edgar Link	pending
0001437749-20-006563.txt	Edgar Link	pending
0001437749-20-006563-xbrl.zip	Edgar Link	pending
ex_172053.htm	Edgar Link	pending
ex_172054.htm	Edgar Link	pending
ex_172055.htm	Edgar Link	pending
ex_172056.htm	Edgar Link	pending
ex_172057.htm	Edgar Link	pending
ex_172058.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
mlss-20191231.xml	Edgar Link	completed
mlss-20191231.xsd	Edgar Link	pending
mlss-20191231_cal.xml	Edgar Link	unprocessable
mlss-20191231_def.xml	Edgar Link	unprocessable
mlss-20191231_lab.xml	Edgar Link	unprocessable
mlss-20191231_pre.xml	Edgar Link	unprocessable
mlss20191231_10k.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss

2019 Q4 Form 10-K Financial Statement

#000143774920006563 Filed on March 30, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLSS MILESTONE SCIENTIFIC INC. Stock $mlss

2019 Q4 Form 10-K Financial Statement

#000143774920006563 Filed on March 30, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss